IL1A and breast carcinoma: For example, a higher level of IL1 has been correlated with more aggressive and high-grade breast cancers, and an elevated level of IL1’s natural antagonist—recombinant IL1 receptor antagonist (IL1RA)—and a lower level of IL1 is a good prognostic indicator for breast cancer patients27–31.